|
| Press Releases |
|
 |
|
| Monday, April 27, 2020 |
|
|
華領醫藥宣佈Dorzagliatin與恩格列淨（一種SGLT-2抑制劑）聯合用藥臨床研究的成功結果 |
| 華領醫藥技術（上海）有限公司（以下簡稱「華領醫藥」，香港聯交所股份代號：2552.HK）宣佈臨床研究HMM0112的成功結果。 more info >> |
|
|
Hua Medicine Announces Positive Results in the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor) |
| Hua Medicine (the "Company", Stock Code: 2552. HK) today announces the positive results of the clinical study HMM0112. more info >> |
|
| Monday, March 16, 2020 |
|
|
华领医药公布2019年全年业绩 |
| 华领医药（「公司」，香港联交所股份代号：2552），一家针对糖尿病临床需求的全球首创新药研发公司，宣布公司及其附属公司截至2019年12月31日止经审核的全年业绩。 more info >> |
|
|
Hua Medicine Announces 2019 Annual Results |
| Hua Medicine (the "Company", Stock Code on The Stock Exchange of Hong Kong Limited: 2552.HK), a global innovative drug research and development company focused on novel therapies for the treatment of diabetes, today announces the audited consolidated results of the Company and its subsidiaries for the year ended December 31, 2019. more info >> |
|
|
華領醫藥公佈2019年全年業績 |
| 華領醫藥（「公司」，香港聯交所股份代號：2552），一家針對糖尿病臨床需求的全球首創新藥研發公司，宣佈公司及其附屬公司截至2019年12月31日止經審核的全年業績。 more info >> |
|
| Friday, February 14, 2020 |
|
|
华领医药任命前美国FDA官员汤福兴博士为首席技术官 |
| 全球糖尿病创新药领军企业华领医药今日宣布，前美国FDA官员、拥有丰富药物制剂研发和药品生产管理经验的汤福兴博士正式加入华领医药，担任首席技术官，负责制剂研发和产品开发，协调华领医药在美国的研发运营。 more info >> |
|
|
華領醫藥任命前美國FDA官員湯福興博士為首席技術官 |
| 全球糖尿病創新藥領軍企業華領醫藥今日宣佈，前美國FDA官員、擁有豐富藥物製劑研發和藥品生產管理經驗的湯福興博士正式加入華領醫藥，擔任首席技術官，負責制劑研發和產品開發，協調華領醫藥在美國的研發運營。 more info >> |
|
|
Hua Medicine appoints Dr. Fuxing Tang, a former U.S. FDA Officer, as Chief Technology Officer |
| Hua Medicine, a leading clinical stage biotechnology company based in Shanghai, is pleased to announce that Dr. Fuxing Tang has joined Hua Medicine as Chief Technology Officer, VP of Formulation R&D and Product Development. more info >> |
|
| Monday, April 25, 2016 |
|
|
華領医薬、5000万ドルのシリーズCラウンドで募集額以上の資金を調達 |
| 中国および世界市場向けに画期的新薬とクラス最高の治療薬を開発する治験段階企業の華領医薬(Hua Medicine)は、シリーズC資金調達で約5000万ドルの米ドルおよび中国人民元建ての投資をクローズしたことを、発表しました。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Singapore's Digital Finance Model in Focus at the BFSI IT Summit - Singapore 2025
Aug 11, 2025 18:26 HKT/SGT
|
|
|
WRC 2025: Shoucheng Showcases Full Robotics Value Chain
Aug 11, 2025 16:27 HKT/SGT
|
|
|
Intellifusion Submits an Application to List on the Hong Kong Stock Exchange: A National Breakthrough in AI Inference Chips
Aug 11, 2025 16:25 HKT/SGT
|
|
|
Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan
Aug 11, 2025 16:25 HKT/SGT
|
|
|
Campaign to promote Hong Kong's advantages in professional services in Vietnam
Aug 11, 2025 16:03: JST
|
|
|
Campaign to promote Hong Kong's advantages in professional services in Vietnam
Aug 11, 2025 15:03 HKT/SGT
|
|
|
31 Concept to Debut Patent-Pending Technology at ISS Asia 2025 in Singapore
Aug 11, 2025 13:13 HKT/SGT
|
|
|
31 Concept將在2025年新加坡ISS Asia首度發佈其申請專利的新技術
Aug 11, 2025 13:13 HKT/SGT
|
|
|
Qube Celebrates 20 Years of Business Events Impact with Industry Recognition and Vision for the Future
Aug 11, 2025 12:03 HKT/SGT
|
|
|
TransNusa Focuses on Organic Growth to Strengthen Network Connectivity in China
Aug 11, 2025 11:00 HKT/SGT
|
|
|
沙烏地電力公司2025年第二季淨利成長22%
Aug 11, 2025 11:00 HKT/SGT
|
|
|
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
Aug 11, 2025 10:41 HKT/SGT
|
|
|
康灃生物中期業績創紀錄 呼吸介入產品驅動收入激增162%
Aug 11, 2025 10:41 HKT/SGT
|
|
|
康沣生物中期业绩创纪录 呼吸介入产品驱动收入激增162%
Aug 11, 2025 10:41 HKT/SGT
|
|
|
Shoucheng-Backed Data Center REITs Surge on Market Debut
Aug 11, 2025 09:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
